Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 246 for “"Drug combination"”.

  1. Machine Learning Approaches for Drug Combination Discovery

    Drugs used in combination therapy has superior treatment efficacy. Preclinical experimental screenings have fueled this progress by identifying and prioritizing new candidate combinations, but they lack predictive power over the transcriptomic data of individualized cancer samples in which …

    cornell Repository record for Machine Learning Approaches for Drug Combination Discovery (opens in a new tab)

  2. Synergistic Drug Combination Treatments Reveal Signaling Pathways Involving CaMKK2

    … of diverse cell functions. Consequentially, drugs can be used to treat, with enhanced efficacy, a wide variety of diseases with complex signaling networks such as cancer. Accordingly, drugs can be developed to selectively inhibit individual enzymes in these pathways and provide information …

    buffalo Repository record for Synergistic Drug Combination Treatments Reveal Signaling Pathways Involving CaMKK2 (opens in a new tab)

  3. Combining Network Modeling and Experimental Approaches to Predict Drug Combination Responses

    … multi-variate biochemical networks within which drug targets reside and existence and plasticity of multiple cell states. It is generally understood that a combination of drugs is a way to address the multi-faceted drivers of cancer and drug resistance. However, the sheer number of testable …

    clemson Repository record for Combining Network Modeling and Experimental Approaches to Predict Drug Combination Responses (opens in a new tab)

  4. Modeling and Synergy Testing of Drug Combination Data: A Pharmacokinetic Analysis

    … method to assess the mathematical synergy of two-drug combinations based on a stochastic model. The drugs in question are two isomers that are applied to the human eye via a liquid eye drop. Techniques applied to the data in this paper can be applied to other two-drug combination studies. We …

    unf Repository record for Modeling and Synergy Testing of Drug Combination Data: A Pharmacokinetic Analysis (opens in a new tab) Download PDF for Modeling and Synergy Testing of Drug Combination Data: A Pharmacokinetic Analysis (opens in a new tab)

  5. Magnetic sponges for localized and controlled drug delivery with drug combination therapy

    Systemic drug administration (i.e., intravenous injection), leading to drug circulation throughout the body can be associated with adverse side effects. Alternatively, localized drug delivery systems have been developed to focus drug concentrations at target sites. This method of delivery has been …

    ubc Repository record for Magnetic sponges for localized and controlled drug delivery with drug combination therapy (opens in a new tab) Download PDF for Magnetic sponges for localized and controlled drug delivery with drug combination therapy (opens in a new tab)

  6. Delivery of Drug Combination Therapy in Polymeric Nanoparticles for Treatment of Breast Cancer

    … a better safety profile. The use of synergistic drug combination therapies has emerged as one promising avenue towards reducing the toxicities associated with high doses of single agents while maintaining therapeutic efficacy. The molar ratios at which the drugs are administered have significant …

    toronto-retro Repository record for Delivery of Drug Combination Therapy in Polymeric Nanoparticles for Treatment of Breast Cancer (opens in a new tab)

  7. IDENTIFICATION OF AN EFFECTIVE RIBONUCLEOSIDE ANALOGUE AND IMMUNOMODULATORY IMIDE DRUG COMBINATION FOR MULTIPLE MYELOMA

    … the current standard treatments mainly involve combination therapies targeting multiple pathways. Despite rapid advance in therapeutics, MM remains incurable and most patients eventually relapse. To identify effective novel drug combinations against MM, we applied our quadratic phenotypic …

    nus Repository record for IDENTIFICATION OF AN EFFECTIVE RIBONUCLEOSIDE ANALOGUE AND IMMUNOMODULATORY IMIDE DRUG COMBINATION FOR MULTIPLE MYELOMA (opens in a new tab) Download file for IDENTIFICATION OF AN EFFECTIVE RIBONUCLEOSIDE ANALOGUE AND IMMUNOMODULATORY IMIDE DRUG COMBINATION FOR MULTIPLE MYELOMA (opens in a new tab)

  8. HEDGEHOG/HDAC6 INHIBITION AND CHEMOTHERAPY: ASSESSMENT OF NEW DRUG COMBINATION IN ACUTE MYELOID LEUKEMIA

    … genes (GLI1, PTCH1), HDAC6, and the Multi- Drug-Resistant genes (MDRs) ABCC1 and ASXL1 were more expressed than in healthy donors (HD). In addition, through in silico analyses, we verified that in AML patients the expression of Hh/HDAC6 and MDRs genes were positively correlated. We also …

    milano Repository record for HEDGEHOG/HDAC6 INHIBITION AND CHEMOTHERAPY: ASSESSMENT OF NEW DRUG COMBINATION IN ACUTE MYELOID LEUKEMIA (opens in a new tab)

  9. Discovery of Dihydroartemisinin and Dasatinib Drug Combination to Cure Pooroutcome BCR-ABL+ Acute Lymphoblastic Leukemia

    … and chronic myelogenous leukemia (CML). Food and Drug Administration (FDA)- approved BCR-ABL-specific kinase inhibitors (BCR-ABL–KIs) imatinib, dasatinib and nilotinib induce prolonged remissions in CML but poor leukemia-reduction and relapse-control in Ph+ ALL. The relative primary …

    tenn-hsc Repository record for Discovery of Dihydroartemisinin and Dasatinib Drug Combination to Cure Pooroutcome BCR-ABL+ Acute Lymphoblastic Leukemia (opens in a new tab)

  10. Models of Cytokine Dynamics During Cytokine Storms and Synergy During Virus and Drug Combination Therapy

    … possible ways to prevent such immune responses. Combination therapy is a common technique used by many medical professionals. The intention of these therapies is to create synergistic effects in order to effectively treat disease while simultaneously reducing treatment costs, side effects and …

    guelph Repository record for Models of Cytokine Dynamics During Cytokine Storms and Synergy During Virus and Drug Combination Therapy (opens in a new tab)

  11. Engineering immediate release tablets with customized design and drug combination via fused deposition modelling 3d printing

    … dosage forms with customised designs and drug combinations, using fused deposition modelling 3D Printing. Five drugs with different physicochemical properties were investigated to ascertain the practicality of using an immediate release methacrylate polymer (Eudragit EPO) and thermally …

    cent-lancashire Download PDF for Engineering immediate release tablets with customized design and drug combination via fused deposition modelling 3d printing (opens in a new tab)

  12. Adaptive optimal design with application to a two drug combination trial based on efficiency-toxicity response

    … an adaptive optimal design for dose-finding with combination therapies that accounts for both efficacy and toxicity. The bivariate probit model is used as a working model for the dose-response relationship. A desirable therapy is defined to be the dose combination that achieves a preset …

    missouri Repository record for Adaptive optimal design with application to a two drug combination trial based on efficiency-toxicity response (opens in a new tab)

  13. Development and evaluation of a solid oral dosage form for an artesunate and mefloquine drug combination

    … and parasite resistance to existing antimalarial drugs such as mefloquine has already reached disturbingly high levels in South-East Asia and on the African continent. Consequently, there is a dire need for new drugs or formulations in the prophylaxis and treatment of malaria. Artesunate, an …

    nwu-za Repository record for Development and evaluation of a solid oral dosage form for an artesunate and mefloquine drug combination (opens in a new tab)

  14. Elucidating Mechanisms for Drug Combination Nanoparticles to Enhance and Prolong Lymphatic Exposure: Experimental and Modeling Approaches

    … enhanced and prolonged lymphatic exposure to drug combinations is essential for treating these diseases. Unfortunately, many oral and intravenous small molecule drug therapies exhibit limited lymphatic exposure, which can lead to subtherapeutic drug levels and drug resistance. Moreover, most …

    washington Repository record for Elucidating Mechanisms for Drug Combination Nanoparticles to Enhance and Prolong Lymphatic Exposure: Experimental and Modeling Approaches (opens in a new tab)

  15. Sample size determination for Emax model, equivalence / non-inferiority test and drug combination in fixed dose trials.

    … used models defining the relationship of drug efficacy with respect to its dosing levels in pharmacokinetic /pharmacodynamic studies. In frequentist approach, sample sizes are determined by desired accuracy for the parameter of interest ED₅₀. Non-linear mixed effects model is applied to …

    baylor Repository record for Sample size determination for Emax model, equivalence / non-inferiority test and drug combination in fixed dose trials. (opens in a new tab)

  16. Polymer and Lipid-based Nanomedicine of Synergistic Drug Combination for Improving Chemotherapy of Multidrug Resistant Breast Cancer

    … cancer. The development of multifactorial multidrug resistance (MDR), however, remains a significant obstacle contributing to treatment failure. The goal of this thesis is to investigate an emerging polymer-lipid hybrid nanoparticle (PLN) system for co-delivering synergistic drug combinations to …

    toronto-retro Repository record for Polymer and Lipid-based Nanomedicine of Synergistic Drug Combination for Improving Chemotherapy of Multidrug Resistant Breast Cancer (opens in a new tab)

  17. Advancing Treatments for Leukemia and Metastatic Pancreatic Cancer with Targeted, Synchronized Delivery of Drug Combination Stabilized in Nanoparticles

    … Americans due to an inability of the treatment drugs to properly target and accumulate at the cancer and tumor sites in the body. Leukemia (blood cancer) treatments that can temper the disease without truly curing it are now common first-line regimens, with some patients even experiencing …

    washington Repository record for Advancing Treatments for Leukemia and Metastatic Pancreatic Cancer with Targeted, Synchronized Delivery of Drug Combination Stabilized in Nanoparticles (opens in a new tab)

  18. Analytical methods to determine the degree of drug association for complex injectable drug-combination particles containing multiple drug substances

    … complex injectable products composed of multiple drug substances targeted to human immunodeficiency virus (HIV). Some of these product candidates are composed of current HIV drug substances that exhibit desperate water solubilities. For example, lopinavir (LPV), ritonavir (RTV) and dolutegravir …

    washington Repository record for Analytical methods to determine the degree of drug association for complex injectable drug-combination particles containing multiple drug substances (opens in a new tab)

  19. Developing Novel Antifungal Compounds for Use as Single-Agent and in Multi-Drug Combination Therapies for Treating Invasive Fungal Infections

    … there is an immediate need for antifungal drug development. Current antifungal therapies are antiquated, have numerous side effects, and consist of only four available classes. The development of novel drugs to treat fungal disease is hindered by the evolutionary conservation between fungi …

    duke Repository record for Developing Novel Antifungal Compounds for Use as Single-Agent and in Multi-Drug Combination Therapies for Treating Invasive Fungal Infections (opens in a new tab)

  20. Development and Characterization of an Orthotopic Pancreatic Ductal Adenocarcinoma (PDAC) Tumor Model for Evaluation of Drug-Combination Nanomedicine and Targeted Therapeutics

    … potential influence of genetic modifications on drug response mechanisms. Pharmacokinetic studies revealed that a novel gemcitabine-and-paclitaxel drug-combination-nanoparticle formulation (GT-in-DcNP) significantly improved the exposure and bioavailability of soluble gemcitabine and paclitaxel. …

    washington Repository record for Development and Characterization of an Orthotopic Pancreatic Ductal Adenocarcinoma (PDAC) Tumor Model for Evaluation of Drug-Combination Nanomedicine and Targeted Therapeutics (opens in a new tab)

Page 1 of 13